Daclatasvir

SL-757

Daclatasvir, >98%

CAS No. : [1009119-64-5]

MDL No. : MFCD18074519

Synonyms : BMS-790052; BMS-052; S-1482; EBP-883

IUPAC Name : Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
50MG	85.00		Back Order	Estimated to ship on 04 October 2026
250MG	95.00		Back Order	Estimated to ship on 04 October 2026
1G	195.00		Back Order	Estimated to ship on 04 October 2026
5G	995.00		Back Order	Estimated to ship on 04 October 2026

Applications : Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides and it became potential therapeutic agent for the HCV treatment.

References : Chukkapalli V. et.al.: Virology 476, 168, 2015.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.